Warfarin treatment in patients with atrial fibrillation and advanced chronic kidney disease: sins of omission or commission?

JAMA. 2014 Mar 5;311(9):913-5. doi: 10.1001/jama.2014.1781.

Authors

Wolfgang C Winkelmayer¹, Mintu P Turakhia²

Affiliations

¹ Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California2Department of Health Research and Policy, Stanford University School of Medicine, Palo Alto, California3Associate Editor, JAMA.
² Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Palo Alto, California5Veterans Affairs Palo Alto Health Care System, Palo Alto, California.

PMID: 24595773
DOI: 10.1001/jama.2014.1781

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / therapeutic use*
Atrial Fibrillation / complications*
Female
Humans
Male
Myocardial Infarction / complications*
Renal Insufficiency, Chronic / complications*
Warfarin / therapeutic use*

Substances

Anticoagulants
Warfarin